Product Code: 137123-08-22
Industry Outlook
Interventional radiology involves performing surgical and diagnostic procedures with image guidance. Interventional radiology procedures are generally classified into two types, namely, percutaneous procedures and endovascular procedures. Advent of minimally invasive procedures, their favorable outcomes, and corresponding growth in demand for such procedures are driving the growth of Interventional Radiology Products Market. Minimally invasive procedures are observed to be more effective in treating conditions as against traditional procedures and inure low cost, have less hospital stay, improved comfort and lower risk of infection. The need for readmission from minimally invasive procedures is also less. Image guided minimally invasive surgeries are being increasingly adopted in treating conditions that were previously mandated only for conventional open surgeries. Trauma is one such area where interventional radiology is experiencing phenomenal adoption.
The field of interventional radiology has swiftly advanced to become a subspecialty. Market players in this industry have involved in merger and acquisitions strategies, enabling companies to expand their international presence along with business area. In addition, exchange of technologies and R&D processes is also prominent among the market players. Therefore, M&A activities, partnerships and collaborations are the key strategies expected to continue through the forecast period.
The global interventional radiology products market was valued at US$ 8,888.2 Mn in 2021 and expected to reach US$ 13,373.6 Mn by 2030, expanding at a CAGR of 4.6% from 2022 to 2030.
"Catheters and Guidewires to Occupy the Largest Revenue Share"
The standard devices used in guided interventions cannot be used in interventional radiology due to their ferromagnetic components and conducting materials, resulting in risk of radiofrequency-induced heating. Many of the catheters, and balloons available in the market are not yet CE or FDA market for MRI guidance. The interventional radiology specialty is still restricted from the lack of appropriate radiology compatible instruments. Nylon, polyester, aramid and other fibers are viewed as viable solutions for the construction of fiber-braided catheters with improved properties. The magnetic resonance electrophysiology catheter developed from nylon braided tubing; is demonstrated to have better mechanical properties than conventional catheters. Such fiber-reinforced catheters therefore possess the potential to be used as a superior solution in radiological interventions. Several catheter developments for MR are being reported in the market. Companies are increasingly developing interest in developing interventional radiology catheters for procedures such as cardiac electrophysiology, renal and cardiac ablation catheters deflectable catheters and tracking catheters.
"Angioplasty and Angiography Spearhead the Global Market, Attributed to High Procedure Rate"
Angiography is commonly used for diagnostic examination of blood vessels. It is among the most common procedures where radiology is the standard guidance mode. In several cases, therapeutic intervention performed with stent insertion and angioplasty or embolization procedures to reduce or stop blood flow through a vessel. Diagnosis of arterial disease is often performed through CT angiography or MR angiography. Catheter angiography remains the gold standard for arterial condition diagnosis and allows treatment of the detected issue during the same time. Growing incidence of cardiovascular diseases and stroke is the key factor contributing to the dominance of this segment. Sedentary lifestyle, growing consumption of processed foods with sugar, salt and fats, changing dietary habits and rapidly increasing senescent population are the key drivers of the above fact.
"Neurology Segment Set to Progress at Rapid Growth Rate"
Swift progress of medical imaging technology and the ability to leverage the knowledge in interventional procedures has placed interventional neuroradiology at a prominent position to incorporate minimally invasive procedures into clinical management and advanced patient care. Significant opportunities lie in this segment to change the management of variety of neurological diseases through the use of minimally invasive guided procedures. Growing clinical presence of interventional radiology has several advantages in the procedure driven clinical environment.
"Asia Pacific Set to Become a Lucrative Market for Interventional Radiology"
At present, North America is the largest revenue generating regional market for interventional radiology products. Higher reimbursements, greater awareness along with higher patient population with chronic diseases are the key factors supporting the dominance of North America. Asia Pacific, however, is estimated to progress at a faster growth rate during the forecast period. Neural and tumor interventions along with cardiac applications are the most common procedures with interventionists in Asia Pacific. In China, cerebral angiography is the most common IR procedure performed in China, followed by percutaneous transluminal angioplasty, percutaneous transhepatic cholangiography, cerebral aneurysm interventions and transcatherer arterial chemoembolization. Rapid evolution of healthcare infrastructure, burgeoning medical tourism, and improving skills of medical personnel are the key factors supporting the swift CAGR of Asia Pacific market.
The prevailing dynamics in the global interventional radiology products market are studied based on the drivers, challenges, opportunities, attractive investment proposition and market dynamics. The market dynamics studied in the report give insights on the positive aspects and pain points prevalent in the market. Major players in this industry are also scrutinized in terms of business description, financial information, product portfolio and key developments. The prominent market players profiled in this report include GE Healthcare, Siemens AG, Koninklijke Philips N.V., Carestream Health, Hologic, Inc., Shimadzu Corporation, Hitachi Medical Systems, Cardinal Health, Inc., Fujifilm Holdings Corporation, Medtronic plc., Teleflex Incorporated, Toshiba Medical Systems Corporation and C. R. Bard.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Interventional Radiology Products market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Interventional Radiology Products market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Products
Catheters
Stents
Guidewires
Inferior Vena Cava Filters
Hemodynamic Flow Alteration Devices
Thrombectomy Systems
Angioplasty Balloons
Embolization Devices
Biopsy Devices
Accessories and Others
Contrast Media
Inflation Devices
Others
Procedure
Angiography
Angioplasty
Biopsy and Drainage
Embolization
Thrombolysis
Vertebroplasty
Nephrostomy
Other Procedures
Application
Cardiology
Urology and Nephrology
Obstretrics and Gynecology
Abdominal and Gastrointestinal
Neurology
Oncology
Others
Region Segment (2020-2030; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Global Impact of Covid-19 Segment (2020-2021; US$ Million )
Pre Covid-19 situation
Post Covid-19 situation
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Interventional Radiology Products market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2030.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Interventional Radiology Products market?
Which is the largest regional market for Interventional Radiology Products market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Interventional Radiology Products market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Interventional Radiology Products market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Interventional Radiology Products Market
- 2.2. Global Interventional Radiology Products Market, By Products, 2021 (US$ Million)
- 2.3. Global Interventional Radiology Products Market, By Procedure, 2021 (US$ Million)
- 2.4. Global Interventional Radiology Products Market, By Application, 2021 (US$ Million)
- 2.5. Global Interventional Radiology Products Market, By Geography, 2021 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2021
3. Interventional Radiology Products Market: Competitive Analysis
- 3.1. Market Positioning of Key Interventional Radiology Products Market Vendors
- 3.2. Strategies Adopted by Interventional Radiology Products Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2021 Versus 2030
4. Interventional Radiology Products Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Interventional Radiology Products Market Value, 2020 - 2030, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2021 Versus 2030
- 5.3. Market Segmentation
- 5.3.1. Catheters
- 5.3.2. Stents
- 5.3.3. Guidewires
- 5.3.4. Inferior Vena Cava Filters
- 5.3.5. Hemodynamic Flow Alteration Devices
- 5.3.6. Thrombectomy Systems
- 5.3.7. Angioplasty Balloons
- 5.3.8. Embolization Devices
- 5.3.9. Biopsy Devices
- 5.3.10. Accessories and Others
- 5.3.10.1. Contrast Media
- 5.3.10.2. Inflation Devices
- 5.3.10.3. Others
6. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2021 Versus 2030
- 6.3. Market Segmentation
- 6.3.1. Angiography
- 6.3.2. Angioplasty
- 6.3.3. Biopsy and Drainage
- 6.3.4. Embolization
- 6.3.5. Thrombolysis
- 6.3.6. Vertebroplasty
- 6.3.7. Nephrostomy
- 6.3.8. Other Procedures
7. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2021 Versus 2030
- 7.3. Market Segmentation
- 7.3.1. Cardiology
- 7.3.2. Urology and Nephrology
- 7.3.3. Obstretrics and Gynecology
- 7.3.4. Abdominal and Gastrointestinal
- 7.3.5. Neurology
- 7.3.6. Oncology
- 7.3.7. Others
8. North America Interventional Radiology Products Market, 2020-2030, USD (Million)
- 8.1. Market Overview
- 8.2. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 8.3. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 8.4. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 8.5.Interventional Radiology Products Market: By Region, 2020-2030, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 8.5.1.1.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 8.5.1.1.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 8.5.1.2.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 8.5.1.2.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 8.5.1.3.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 8.5.1.3.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
9. UK and European Union Interventional Radiology Products Market, 2020-2030, USD (Million)
- 9.1. Market Overview
- 9.2. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 9.3. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 9.4. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 9.5.Interventional Radiology Products Market: By Region, 2020-2030, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 9.5.1.1.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 9.5.1.1.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 9.5.1.2.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 9.5.1.2.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 9.5.1.3.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 9.5.1.3.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 9.5.1.4.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 9.5.1.4.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 9.5.1.5.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 9.5.1.5.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 9.5.1.6.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 9.5.1.6.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
10. Asia Pacific Interventional Radiology Products Market, 2020-2030, USD (Million)
- 10.1. Market Overview
- 10.2. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 10.3. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 10.4. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 10.5.Interventional Radiology Products Market: By Region, 2020-2030, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 10.5.1.1.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 10.5.1.1.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 10.5.1.2.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 10.5.1.2.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 10.5.1.3.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 10.5.1.3.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 10.5.1.4.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 10.5.1.4.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 10.5.1.5.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 10.5.1.5.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 10.5.1.6.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 10.5.1.6.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
11. Latin America Interventional Radiology Products Market, 2020-2030, USD (Million)
- 11.1. Market Overview
- 11.2. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 11.3. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 11.4. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 11.5.Interventional Radiology Products Market: By Region, 2020-2030, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 11.5.1.1.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 11.5.1.1.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 11.5.1.2.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 11.5.1.2.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 11.5.1.3.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 11.5.1.3.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
12. Middle East and Africa Interventional Radiology Products Market, 2020-2030, USD (Million)
- 12.1. Market Overview
- 12.2. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 12.3. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 12.4. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 12.5.Interventional Radiology Products Market: By Region, 2020-2030, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 12.5.1.1.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 12.5.1.1.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 12.5.1.2.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 12.5.1.2.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Interventional Radiology Products Market: By Products, 2020-2030, USD (Million)
- 12.5.1.3.1. Interventional Radiology Products Market: By Procedure, 2020-2030, USD (Million)
- 12.5.1.3.1. Interventional Radiology Products Market: By Application, 2020-2030, USD (Million)
13. Company Profile
- 13.1. GE Healthcare
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. Siemens AG
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. Koninklijke Philips N.V.
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. Carestream Health
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. Hologic Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. Shimadzu Corporation
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. Hitachi Medical Systems
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. Cardinal Health, Inc.
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. Fujifilm Holdings Corporation
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. Medtronic plc.
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. Teleflex Incorporated
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
- 13.12. Toshiba Medical Systems Corporation
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives
- 13.13. C. R. Bard
- 13.13.1. Company Overview
- 13.13.2. Financial Performance
- 13.13.3. Product Portfolio
- 13.13.4. Strategic Initiatives